Drug Type Small molecule drug |
Synonyms GS 0272, GS0272 |
Target |
Mechanism BTLA blockers(B- and T-lymphocyte attenuator blockers) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Rheumatoid Arthritis | Phase 1 | US | 28 Sep 2023 | |
Rheumatoid Arthritis | Phase 1 | GE | 28 Sep 2023 | |
Rheumatoid Arthritis | Phase 1 | MD | 28 Sep 2023 | |
Rheumatoid Arthritis | Phase 1 | GB | 28 Sep 2023 |